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The aim of the present study was to reveal the characteristic features of genital Chlamydia suis infection and
re-infection in female pigs by studying the immune response, pathological changes, replication of chlamydial
bacteria in the genital tract and excretion of viable bacteria. Pigs were intravaginally infected and re-infected with
C. suis strain S45, the type strain of this species. We demonstrated that S45 is pathogenic for the female urogenital
tract. Chlamydia replication occurred throughout the urogenital tract, causing inflammation and pathology.
Furthermore, genital infection elicited both cellular and humoral immune responses. Compared to the primo-infection
of pigs with C. suis, re-infection was characterized by less severe macroscopic lesions and less chlamydial elementary
bodies and inclusions in the urogenital tract. This indicates the development of a certain level of protection following
the initial infection. Protective immunity against re-infection coincided with higher Chlamydia-specific IgG and IgA
antibody titers in sera and vaginal secretions, higher proliferative responses of peripheral blood mononuclear cells
(PBMC), higher percentages of blood B lymphocytes, monocytes and CD8+ T cells and upregulated production of
IFN-γ and IL-10 by PBMC.Introduction
Chlamydia suis is widespread in commercial pig produc-
tion and causes important economic losses [1]. C. suis in-
fections are associated with a variety of diseases including
conjunctivitis [2], rhinitis [3], pneumonia [3,4], enteritis
[5,6], periparturient dysgalactiae syndrome (PDS) [7] and
numerous reproductive disorders [1,7-10] such as abor-
tion, mummification, perinatal and neonatal mortality,
repeat breeding, vaginal discharge and endometritis in
addition to orchitis, epididymitis and urethritis in boars
[11]. C. suis has also been detected in the semen of boars,
suggesting the possibility of venereal transmission during
mating or artificial insemination [1,12,13]. Furthermore,
C. suis has frequently been identified in asymptomatic
carriers [14-16].
Experimental infection of gnotobiotic and convention-
ally raised pigs with C. suis proved its pathogenic potential
for the porcine respiratory system [3,4,17], gastrointestinal
tract [5,6,18] and eyes [2]. In contrast, the exact role of* Correspondence: eadclerc.declercq@ugent.be
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To our knowledge, experimental genital tract infection
of pigs with C. suis has never been performed before.
Nevertheless, considering the possibility of venereal
transmission, genital C. suis infections and re-infections
are probably common in breeder sows, since they are
mated or inseminated a minimum of twice a year and
generally two to three inseminations per oestrus are car-
ried out. In the present study, conventionally raised
Chlamydia-negative pigs were intravaginally infected
and/or re-infected with C. suis strain S45, the type strain
of this species. The aim of this study was to reveal the
characteristic features of a genital C. suis infection and
re-infection in female pigs by studying the immune re-
sponse, pathological changes, replication of chlamydiae
in the genital tract and excretion of viable bacteria.Materials and methods
Chlamydia suis
C. suis strain S45 (kindly donated by A. Andersen, National
Animal Disease Center, USDA Agriculture Research
Service, Ames, Iowa) was used to infect the pigs. Thisral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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asymptomatic Austrian pig [19]. The bacteria were grown
in McCoy cells using standard techniques [20]. The 50%
Tissue Culture Infective Dose (TCID50) was determined
by the method of Spearman and Kaerber [21]. TCID50/mL
is routinely used for titrating intracellular organisms like
viruses in cell cultures and it correlates with IFU/mL as
examined by Beeckman et al. [22].
Infection experiment
Fifteen 9-week-old conventionally bred female pigs
(Belgian Landrace) were randomly divided into three
groups of five pigs. Antibodies against Chlamydiaceae
were absent as determined by a C. suis ELISA using
purified elementary bodies (EBs) of strain S45. Nasal,
rectal and vaginal swabs did not contain chlamydial bac-
teria as determined by culture on McCoy cells. The ani-
mals were housed in isolation units and fed ad libitum
with a commercial starting diet. At day 0, all pigs were
anesthetized by intramuscular injection of Zoletil® 100
(Virbac Animal Health, Louvain La Neuve, Belgium) in
2% Xylazine-M® (VMD, Arendonk, Belgium). The con-
trol group and the infection group were inoculated with
phosphate-buffered saline (PBS). The re-infection group
was infected by intravaginal injection of 1 × 107 TCID50
of C. suis strain S45. Intravaginal inoculation was per-
formed by inserting an artificial insemination pipette
connected to a syringe into the vagina and injecting the
bacterial suspension in 1 mL PBS or injecting simply
1 mL PBS (controls). At day 56, pigs were anesthetized
again, whereafter the control group was inoculated with
PBS and the infection group and the re-infection group
were infected intravaginally with C. suis strain S45 (1 × 107
TCID50). All groups were euthanized at day 77 by intra-
venous injection of an overdose of pentobarbital
(70 mg/kg; Nembutal®, Ceva Santé Animale, Maassluis,
the Netherlands) followed by exsanguination.
Vaginal swabs in 2 mL Chlamydia transport medium
for chlamydial isolation and in 2 mL PBS with protease
inhibitor for mucosal antibody detection were collected
weekly. Swabs were stored at −80 °C until analysis. Blood
for antibody detection was sampled from the jugular vein
(v. jugularis) weekly. Blood samples were stored overnight
at room temperature and centrifuged (9300 × g, 20 °C,
10 min) for serum collection. Sera were stored at −20 °C
until tested. At euthanasia, pigs were examined for gross
lesions that were scored as none (0), slight (1), moderate
(2) or severe (3). Samples of the spleen, liver, caecum,
urethra, vagina, cervix, corpus uteri, uterine tubes, ovi-
ducts and ovaries were imbedded in methylcellulose
medium, frozen in liquid nitrogen and stored at −80 °C
until preparation of cryostat tissue sections for localization
and quantification of the infection. Samples from the same
tissues were taken for histopathology. The experimentalprocedure was approved by the animal care and ethical
committee of Ghent University (EC2012/078).
Chlamydial antigen detection
Vaginal swabs in Chlamydia transport medium were
shaken for 1 h at 4 °C, centrifuged and cultured in
McCoy cells grown on 13 mm cover slips in Chlamydia
Trac Bottles (International Medical, Brussels, Belgium)
as described by Vanrompay et al. [20]. Additionally, cells
were washed twice with 1 mL phosphate buffer supple-
mented with 0.003% DEAE-dextran before the inoculum
was added to the cells. Chlamydial growth was moni-
tored using the IMAGEN™ direct immunofluorescence
staining (Oxoid, Drongen, Belgium) at 6 days post inocula-
tion. Cryostat tissue sections (5 μm) were also stained by
use of the IMAGEN™ immunofluorescence test. All slides
were examined by immunofluorescence microscopy (BX41
Olympus, 600×). Positive cells were counted in five micro-
scopic fields. The calculated mean was presented as a score
ranging from 0 to 6. Score 0 indicated a negative result.
Score 1 and 2 indicated 1 to 5 and 6 to 10 elementary
bodies (EBs) per microscopic field in the absence of inclu-
sions, respectively. Score 3 represented more than 10
elementary bodies and 1 inclusion-positive cell per micro-
scopic field. Score 4, 5 and 6 indicated 1 to 5, 6 to 10 and
more than 10 inclusion-positive cells per microscopic
field, respectively.
Antibody responses
Sera were heat inactivated at 56 °C during 30 min and
subsequently pretreated with kaolin to reduce back-
ground activity [23]. Vaginal swabs in PBS with protease
inhibitor were shaken for 1 h at room temperature and
centrifuged. Isotype-specific serum and mucosal antibody
titers were determined in an ELISA using purified S45
EBs as antigen. Maxisorp 96-well microtiter plates were
coated with purified C. suis strain S45 EBs (1 × 107 TCID50
per well) diluted in PBS. Plates were blocked overnight
(4 °C) with PBS supplemented with 5% bovine serum
albumin (BSA). Serum and mucosal antibody titers were
determined using twofold dilution series in dilution buffer
(PBS + 3% BSA + 0.05% Tween®20), starting at a dilution
of 1:15. Antibody isotype titers were determined using
monoclonal antibodies against swine IgA (mAb 27.8.1),
IgG (mAb 23.3.1b) and IgM (mAb 28.4.1) [24] at a dilu-
tion of 1:15, 1:20 and 1:50, respectively, followed by an
1:5000 dilution of biotinylated anti-mouse IgG (H + L)
(Dako, Glostrup, Denmark). Subsequently, the plates were
incubated with 1:2500 diluted peroxidase-labeled strepta-
vidin (Zymed Laboratories, San Francisco, USA). Finally,
the substrate and chromogene ABTS (2, 2′-Azino-di(3-
ethylbenzthiazoline-6-sulfonate); KPL, Maryland, USA)
was added. Antibody titers were defined as the reciprocal
of the highest dilution that gave an absorbance reading at
Table 1 Monoclonal antibodies used in flow cytometry
Specificity Clone Isotype Reference
CD3 PTT3 IgG1 [27]
CD4 74-12-4 IgG2b [28]
CD8α 11/295/33 IgG2a [29]
CD8β PG164A IgG2a [30]
CD21 BB6-11C9 IgG1 [30]
IgM 28.4.1 IgG1 [24]
MHCII MSA3 IgG2a [31]
SWC3a 74-22-15 IgG1 [28]
TCR1-N4 (δ chain) PGBL22A IgG1 [32]
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seronegative pig serum + twice the standard deviation).
Positive and negative control sera and mucosal secre-
tions originated from a former experimental infection in
pigs [25].
Proliferative responses of PBMC and MC
At 7 and 10 days post infection (dpi) or re-infection, per-
ipheral blood mononuclear cells (PBMC) were isolated
from heparinized blood samples collected from the jugular
vein. Isolation of PBMC was performed by density gradient
centrifugation (500 × g, 18 °C, 25 min) on Lymphoprep™
(Axis-Shield, Oslo, Norway). After lysis of erythrocytes
in ammonium chloride, the cells were washed and
resuspended in leukocyte medium (RPMI-1640 (Life
Technologies, Merelbeke, Belgium) supplemented with
5% heat-inactivated fetal calf serum (Life Technologies),
5 × 10−5 M β-mercaptoethanol (Life Technologies), 1%
non-essential amino acids (Life Technologies), 1% sodium
pyruvate (Life Technologies), 1% L-glutamine (Life Tech-
nologies), 1% penicillin-streptomycin and 1% kanamycin).
At euthanasia, monomorphonuclear cells (MC) were iso-
lated from the spleen, the cervical lymph node (cervicalis
superficialis) and the pelvic lymph nodes (iliaci mediales,
iliaci laterales, sacrales and anorectales). Isolation of MC
was performed by tearing the tissues apart, after the sur-
rounding fat was removed. Subsequently, the erythrocytes
were lysed with ammonium chloride. After centrifugation
(270 × g, 4 °C, 10 min), the cells were washed and resus-
pended in leukocyte medium without β-mercaptoethanol.
PBMC or MC were grown in 96-well tissue culture plates
at a concentration of 5 × 105 cells/well. Proliferation was
tested by adding 105 viable C. suis purified S45 EBs, 10 μg
concanavalin A (ConA) (positive control) or medium
(negative control) to the wells. Each condition was tested
in duplicate. The cells were incubated at 37 °C in a hu-
midified atmosphere with 5% CO2. ConA- or antigen-
induced proliferation was measured by incorporation of
1 μCi/well of 3H-thymidine (Amersham ICN, Bucks, UK)
during the last 16 h of culture, on day 3 and day 4, re-
spectively. Cells were harvested onto glass fiber filter strips
(Perkin Elmer, Life Science, Oosterhout, The Netherlands)
with a cell harvester (Skatron, Liers, Norway). Radioactivity
incorporated into the DNA was measured with a β-scintil-
lation counter (Perkin Elmer). The stimulation index (SI)
was defined as the ratio of the mean counts per minute of
stimulated PBMC or MC versus the mean counts per
minute of the negative control.
Flow cytometric analysis
PBMC and MC from the spleen, cervical and pelvic
lymph nodes were isolated as described above. Flow cy-
tometry was used to analyze the immune cell (sub)
populations in the blood at different time points postinfection and of the spleen, cervical and pelvic lymph
nodes at euthanasia. T cell populations (CD3+CD4+CD8−,
CD3+CD4−CD8+, CD3+CD4+CD8+, CD3+CD4−CD8−, T
cells with a γδ T cell receptor), B cells (MHCII+CD21+,
MHCII+IgM+), monocytes (MHCII+SWC3+), NK cells
(CD3−CD4−CD8+) and plasmacytoid dendritic cells (pDC)
(CD3−CD4+CD8−) were quantified. However, for the lym-
phoid tissues the CD3−CD4+CD8− population does not
exist entirely of pDC, but also contains an unknown
lineage, presumably of myeloid origin [26]. Based on the
used markers, it was impossible to distinguish between
both populations. PBMC and MC (106 cells) were incu-
bated for 20 min in staining buffer (RPMI-1640 + 1% heat-
inactivated FCS) with optimal concentrations of mAbs
(Table 1). Cells stained with isotype-matched irrelevant
mAbs were used to analyze aspecific binding. Subse-
quently, the cells were washed with staining buffer and
incubated (20 min) with the appropriate isotype-specific
Alexa-647-, FITC- or PE- conjugated antibodies (Life
Technologies). Cells were washed with staining buffer
and with PBS and were resuspended in PBS. Data
were acquired on a FACSCanto flow cytometer (Beckton
Dickinson, Erembodegem, Belgium) with a minimum event
count of 50 000 and analyzed with FACSDiva® software.
Doublets were excluded based on FSC-H/FSC-A and
SSC-H/SSC-A plots.
Cytokine secretion by PBMC and MC
PBMC and MC isolated from the spleen, pelvic lymph
nodes and the cervicales superficiales dorsales lymph
nodes were planted in 24-well microtiter plates at a
concentration of 107 cells/well. Subsequently, the cells
were stimulated by adding 105 viable purified S45 EBs to
each well. Supernatant was collected 16, 24, 48 and 72 h
later. The concentration of IL-1β, IL-4, IL-6, IL-8, IL-10,
IL-12p40, IFN-γ and TNF-α in the supernatant was de-
termined using commercially available ELISA kits (DuoSet®
ELISA Development System, R&D Systems, Abingdon,
UK). Assays were performed according to the manufac-
turer’s guidelines.
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Samples were fixed in 10% phosphate-buffered formalin,
dehydrated and embedded in paraffin, sectioned at 5 μm
and stained with haematoxylin and eosin. The samples
were studied blindly. Slides were examined microscopic-
ally (Leitz). The microscopic findings were either graded
(none (0), minimal (1), slight (2), moderate (3), marked
(4) or severe (5) histological change) or indicated as
present or absent without a grade.
Statistical analysis
Statistical analyses were performed using SPSS 22 and
results for all groups were compared by use of the non-
parametric Mann–Whitney U test. Results were consid-
ered significantly different if P < 0.05.
Results
Macroscopic lesions
The mean scores for macroscopic lesions, determined at
necropsy, are presented in Table 2. Macroscopic lesions
were absent in all but one pig of the control group. OneTable 2 Mean scores ± standard deviation (% of positive anim
re-infection group at euthanasia*
Tissue Macroscopic lesion
Vagina Congestion
Serous exudate
Cervix Congestion
Serous exudate
Uterus Congestion
Hypertrophy
Serous exudate
Uterine tubes Congestion
Hypertrophy
Serous exudate
Oviducts Serous exudate
Ovaries Congestion
Lig. Latum uteri Congestion
Mesovarium Congestion
Mesosalpinx Congestion
Spleen Congestion
Enlargement
Liver Congestion
Pelvic lymph nodes Congestion
Enlargement
Cervical lymph node Enlargement
*The mean score ± SD in the control group was 0.0 ± 0.00 for all tissues.
aP < 0.05 for a comparison of the control group and the infection group.
bP < 0.05 for a comparison of the control group and the re-infection group.
cP < 0.05 for a comparison of the infection group and the re-infection group.control animal had a severely inflamed vagina, cervix
and uterus caused by an abnormal vaginal anatomy.
Therefore, that animal was excluded from the experi-
ment. All infected and re-infected animals showed gross
pathology. The macroscopic lesions were generally more
severe for the infection group than for the re-infection
group. Four pigs (80%) of the infection group showed
moderate to severe congestion of the genital tract
(Additional file 1). The genital tract of the remaining pig
(20%) of the infection group was slightly congested. In
the re-infection group, all but one animal (80%) showed
only slight congestion of the genital tract. In the other re-
infected pig, a severely congested genital tract was no-
ticed. In 60% of the pigs of the infection group, a large
amount of clear watery exudate was present in almost
the entire genital tract (Additional file 1), whereas only
one animal (20%) of the re-infection group showed a
moderate amount of watery exudate in the cervix. The
pelvic lymph nodes were enlarged in 80% of the animals
of both infected groups. Congestion of the pelvic lymph
nodes could only be detected in four pigs (80%) of theals) for macroscopic lesions in the infection and the
Infection group Re-infection group
0.0 ± 0.00 0.2 ± 0.45 (20)
0.6 ± 1.34 (20) 0.0 ± 0.00
0.6 ± 1.34 (20) 0.2 ± 0.45 (20)
1.0 ± 1.41 (40) 0.4 ± 0.89 (20)
0.8 ± 1.10 (40) 1.0 ± 1.22 (60)
0.6 ± 1.34 (20) 0.0 ± 0.00
1.6 ± 1.52 (60) 0.0 ± 0.00
1.2 ± 1.10 (60) 0.4 ± 0.55 (40)
0.6 ± 1.34 (20) 0.0 ± 0.00
1.2 ± 1.64 (40) 0.0 ± 0.00
0.6 ± 1.34 (20) 0.0 ± 0.00
0.4 ± 0.89 (20) 0.0 ± 0.00
0.8 ± 0.84 (60) 0.4 ± 0.55 (40)
1.6 ± 1.34 (80)a 0.2 ± 0.45 (20)
1.4 ± 1.52 (60) 0.2 ± 0.45 (20)
0.4 ± 0.89 (20) 0.0 ± 0.00
0.0 ± 0.00 1.0 ± 1.41 (40)
0.2 ± 0.45 (20) 0.0 ± 0.00
1.6 ± 1.14 (80)a,c 0.0 ± 0.00c
2.2 ± 1.3 (80)a 2.0 ± 1.22 (80)b
1.8 ± 1.64 (60) 0.4 ± 0.89 (20)
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and pelvic lymph nodes were significantly different be-
tween the groups.
Chlamydia suis vaginal excretion
The presence of viable C. suis in vaginal swabs was
examined using culture in McCoy cells. Figure 1 shows
the culture scores for vaginal swabs collected at different
time points post infection. All swabs taken at day 0 of
the experiment were Chlamydiaceae negative. Vaginal
swab samples of the control group remained negative
throughout the experiment. Vaginal C. suis shedding was
detected in the infection group from day 59, three
days after infection of those animals, onwards. In the
re-infection group, C. suis excretion was consistently
high from day 3 to day 28 post primo-infection. After
28 dpi, mean culture scores decreased gradually until
re-infection. Thereafter shedding was again consistently
high. Before primo-infection of the infection group, the
mean excretion scores of the re-infection group were
statistically higher than those of the other groups. From
day 59 onwards, vaginal shedding was significantly higher
in the infection group and the re-infection group than in
the control group. After primo-infection of the infection
group, the mean culture scores of both infected groups
did only differ statistically at day 66, when the infection
group had the highest score, and at day 70, when the re-
infection group had the highest score.
Chlamydial antigen detection in the urogenital tract
Table 3 presents the mean scores for the presence of Chla-
mydiaceae in urogenital tissues collected at euthanasia,b,c b,c
b,c b,c b,c
b,c
b,c
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
3 7 10 14 21 28 35
Sc
or
e
Days pos
Re-infection group
Figure 1 Mean scores ± standard deviation for vaginal C. suis sheddin
The mean score ± SD in the control group was 0.0 ± 0.00 for all time points
group. bP < 0.05 for a comparison of the control group and the re-infection
re-infection group.21 days after infection or re-infection of the infection
group and the re-infection group, respectively. All tissue
samples from the non-infected pigs were negative, as were
the spleen, the liver and the caecum of both infected
groups. An ascending chlamydial infection occurred in all
pigs of the infection group and in 4 of 5 pigs of the re-
infection group, as chlamydial EBs and/or intracellular
inclusions were detected in the upper genital tract of those
animals. Intracellular chlamydial inclusions, indicating the
presence of replicating chlamydiae, were detected in the
urethra (20%), vagina (40%), cervix (60%), right uterine
horn (20%), oviducts (20%) and ovaries (40%) of the infec-
tion group. In the re-infection group, chlamydial replica-
tion could only be observed in the urethra of one pig
(20%), the vagina of two pigs (40%) and the right oviduct
of one pig (20%). Overall, more chlamydial EBs and in-
clusions, demonstrated by higher mean scores, occurred
in the urogenital tract of the infection group than of the
re-infection group. Statistical analysis revealed significant
differences between the mean scores of the right uterine
horn and the left oviduct of both infected groups. Further-
more, mean scores for the presence of Chlamydiaceae in
the vagina, right uterine horn, left oviduct and right ovary
of the infection group were statistically higher than for the
control group. In the re-infection group, the level of
Chlamydia replication in the vagina and the urethra
was significantly higher than in the non-infected pigs.
Antibody responses
The C. suis S45-specific IgM, IgG and IgA antibody titers
in serum (Table 4) and vaginal swab samples (Table 5)
were determined following primo- and re-infection. Theb,c
b,c
b,c
a,b
a,b
a,b,c
a,b,c
a,b
42 49 56 59 63 66 70 77
t infection
Infection group
g from 3 to 77 dpi in the infection and the re-infection group.
. aP < 0.05 for a comparison of the control group and the infection
group. cP < 0.05 for a comparison of the infection group and the
Table 3 Mean scores ± standard deviation for the
presence of C. suis in urogenital tissues of the infection
and the re-infection group at euthanasia*
Tissue Infection group Re-infection group
Vagina 1.80 ± 1.10a 2.00 ± 1.41b
Cervix 2.00 ± 1.87 0.40 ± 0.55
Corpus uteri 0.80 ± 0.45 0.20 ± 0.45
Uterine horn R 1.40 ± 0.89a,c 0.40 ± 0.55c
Uterine horn L 0.20 ± 0.45 0.40 ± 0.55
Oviduct R 0.80 ± 1.30 0.80 ± 1.30
Oviduct L 1.40 ± 0.89a,c 0.50 ± 0.58c
Ovary R 1.60 ± 1.34a 0.20 ± 0.45
Ovary L 0.80 ± 1.30 0.00 ± 0.00
Urethra 1.20 ± 1.30 1.20 ± 1.10b
*The mean score ± SD in the control group was 0.00 ± 0.00 for all tissues.
aP < 0.05 for a comparison of the control group and the infection group.
bP < 0.05 for a comparison of the control group and the re-infection group.
cP < 0.05 for a comparison of the infection group and the re-infection group.
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and vaginal secretion throughout the experiment. Before
infection, no serum or vaginal antibodies were detected in
the animals of the infection and the re-infection group.
Primo-infection induced IgM and IgG, but no IgA anti-
bodies in serum and vaginal secretion. C. suis S45-specific
serum IgM and IgG were observed from 7 days post
primo-infection onwards and mean titers peaked at 14 or
21 dpi. Vaginal antichlamydial IgM and IgG antibodies ap-
peared at 14 and at 14 and 21 days post primo-infection,Table 4 Mean C. suis S45-specific IgM, IgG and IgA serum titers
deviation*
Dpi Procedure Serum IgM
Infection group Re-infection group
0 Infection R 0 ± 0.00 0 ± 0.00
7 0 ± 0.00c 30 ± 0.00b,c
14 0 ± 0.00c 168 ± 98.59b,c
21 0 ± 0.00c 60 ± 0.00b,c
28 0 ± 0.00 0 ± 0.00
35 0 ± 0.00 0 ± 0.00
42 0 ± 0.00 0 ± 0.00
49 0 ± 0.00 0 ± 0.00
56 Infection I & R 0 ± 0.00 0 ± 0.00
63 30 ± 0.00a 30 ± 0.00b
70 216 ± 53.67a,c 42 ± 16.43b,c
77 Euthanasia 72 ± 26.83a 60 ± 0.00b
*The mean IgM, IgG and IgA serum antibody titers ± SD in the control group and th
points. Antibody titers were defined as the reciprocal of the highest dilution that gave
seronegative pig serum + twice the standard deviation).
aP < 0.05 for a comparison of the control group and the infection group.
bP < 0.05 for a comparison of the control group and the re-infection group.
cP < 0.05 for a comparison of the infection group and the re-infection group.respectively. Seven days after re-infection, mean C. suis-
specific serum IgM and IgG titers had increased again and
they kept on rising towards euthanasia. Antichlamydial
mucosal IgM and IgG antibodies were detected from
7 to 14 and from 7 to 21 days post re-infection, respect-
ively. Moreover, C. suis-specific serum and vaginal IgA
antibodies appeared from 14 days following re-infection
onwards. Compared to the antibody responses after
primo-infection, re-infection with C. suis S45 induced
lower IgM antibody titers and higher antichlamydial IgG
and IgA titers, which is illustrative for a secondary anti-
body response.
Proliferative responses of PBMC and MC
Proliferative responses of PBMC to C. suis strain S45
were determined 7 and 10 days post primo-infection of
the re-infection group, and again at day 63 and day 66, 7
and 10 days post infection or re-infection of the infec-
tion group and the re-infection group, respectively. At
day 7 and 10, the proliferative activities of PBMC of all
groups were statistically the same (data not shown). At
day 63, the mean stimulation index (SI ± SD) of the
PBMC for the control group, the infection group and
the re-infection group were 2.03 ± 1.42, 2.15 ± 1.23 and
8.80 ± 5.46, respectively. The PBMC of the re-infection
group showed significantly higher proliferative responses
than the PBMC of the other groups. At day 66, the mean
SI ± SD of the PBMC for the control, the infection
and the re-infection group were 7.42 ± 2.87, 2.24 ± 1.35
and 7.29 ± 3.39. The proliferative activity of PBMC of theof the infection (I) and the re-infection (R) group ± standard
Serum IgG Serum IgA
Infection group Re-infection group Re-infection group
0 ± 0.00 0 ± 0.00 0 ± 0.00
0 ± 0.00c 48 ± 16.43b,c 0 ± 0.00
0 ± 0.00c 240 ± 0.00b,c 0 ± 0.00
0 ± 0.00c 144 ± 90.99b,c 0 ± 0.00
0 ± 0.00c 36 ± 13.42b,c 0 ± 0.00
0 ± 0.00c 48 ± 16.43b,c 0 ± 0.00
0 ± 0.00c 36 ± 13.42b,c 0 ± 0.00
0 ± 0.00c 54 ± 39.12b,c 0 ± 0.00
0 ± 0.00c 48 ± 16.43b,c 0 ± 0.00
45 ± 21.21a,c 264 ± 131.45b,c 0 ± 0.00
120 ± 0.00a,c 336 ± 131.45b,c 30 ± 0.00b,c
195 ± 178.12a,c 816 ± 321.99b,c 60 ± 0.00b,c
e mean IgA serum titers ± SD in the infection group were 0 ± 0.00 for all time
an absorbance reading at 405 nm above the cut-off value (mean absorbance of
Table 5 Mean C. suis S45-specific IgM, IgG and IgA mucosal (vaginal) titers of the infection (I) and the re-infection (R)
group ± standard deviation*
Dpi Procedure Mucosal IgM Mucosal IgG Mucosal IgA
Infection group Re-infection group Infection group Re-infection group Re-infection group
0 Infection R 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00
7 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00
14 0 ± 0.00c 60 ± 0.00b,c 0 ± 0.00c 54 ± 13.42b,c 0 ± 0.00
21 0 ± 0.00 0 ± 0.00 0 ± 0.00c 30 ± 0.00b,c 0 ± 0.00
28-49 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00
56 Infection I & R 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00
63 0 ± 0.00c 30 ± 0.00b,c 0 ± 0.00c 48 ± 16.43b,c 0 ± 0.00
70 48 ± 16.43a,c 24 ± 13.42b,c 60 ± 0.00a,c 96 ± 32.86b,c 24 ± 13.42b,c
77 Euthanasia 0 ± 0.00 0 ± 0.00 96 ± 32.86a,c 48 ± 16.43b,c 30 ± 0.00b,c
*The mean IgM, IgG and IgA mucosal antibody titers ± SD in the control group and the mean IgA mucosal titers ± SD in the infection group were 0 ± 0.00 for all
time points. Antibody titers were defined as the reciprocal of the highest dilution that gave an absorbance reading at 405 nm above the cut-off value (mean
absorbance of seronegative pig serum + twice the standard deviation).
aP < 0.05 for a comparison of the control group and the infection group.
bP < 0.05 for a comparison of the control group and the re-infection group.
cP < 0.05 for a comparison of the infection group and the re-infection group.
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group and the re-infection group. However, at day 66, the
PBMC of the control group showed significantly higher
proliferative responses to the positive control ConA, a T
cell mitogen, than the PBMC of the other groups (data
not shown). This indicates that the PBMC of the control
group had a higher proliferative capacity than the other
groups at that time and explains the high SI following
stimulation with C. suis for the control group. At eu-
thanasia, proliferative responses of MC from the spleen,
cervical and pelvic lymph nodes were statistically the same
for all groups (data not shown).
Immune cell populations
Blood immune cell populations were analyzed by flow
cytometry at 7 and 10 days post primo-infection of the
re-infection group and again at day 63 and day 66, 7 and
10 days post infection or re-infection of the infection
group and the re-infection group, respectively (Additional
files 2 and 3). Seven days post primo-infection of the re-
infection group, the infected animals had a significantly
lower mean percentage of CD4+ T cells than the non-
infected animals. At day 10, a significantly lower percent-
age of T cells was noticed in the re-infection group than in
the infection group. At day 63, the re-infected animals had
significantly higher mean percentages of T cells, B cells
and monocytes, but a significantly lower mean percentage
of pDC as compared to the control group or the infection
group. Within total T cells, significantly less CD4+CD8− T
cells were present in the re-infection group than in the
infection group. At day 66, the re-infection group had
significantly higher percentages of B cells and CD4−CD8+
T cells. At that time, a significantly lower percentage of
monocytes was detected in the infection group than in theother groups. Furthermore, immune cell populations in
the spleen, cervical and pelvic lymph nodes were analyzed
at euthanasia (Additional files 2 and 3). For the spleen, the
mean percentage of T cells was significantly lower in
the re-infection group than in the other groups and
within total T cells significantly less CD4+CD8+ and
CD4−CD8+ T cells and significantly more CD4+CD8− T
cells were present in the re-infection group. Moreover, the
re-infection group had significantly lower mean percent-
ages of B cells and monocytes in the spleen as compared
to the control group, but a significantly higher percentage
of CD3−CD4+CD8− spleen MC, which contain pDC, than
the other groups. The mean percentage of NK cells in the
spleen was significantly higher for the infection group. For
the cervical lymph nodes, significantly higher mean
percentages of CD4+CD8− T cells, B cells and mono-
cytes, besides a significantly lower mean percentage of
CD3−CD4+CD8− MC, containing pDC, were noticed
in the non-infected animals. For the pelvic lymph nodes,
the control pigs had significantly higher mean percentages
of γδ T cells, IgM+ B cells and monocytes. The mean per-
centage of NK cells was significantly higher for the infec-
tion group than for the re-infected animals. Within total
T cells, significantly more CD4−CD8+ T cells were detec-
ted in the re-infection group than in the other groups.
Cytokine secretion by PBMC and MC
Results for cytokine detection at 16 h and 72 h post
stimulation are presented in Additional files 4 and 5.
Data of cytokine production at 24 h and 48 h post stimu-
lation are not shown, since the results were either with-
out statistical differences between the groups or with
statistical differences similar to these observed at 72 h
post stimulation. Compared to the amount of cytokines
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had produced generally more IFN-γ, TNF-α, IL-6 and
IL-10 and less IL-1β at 72 h after stimulation. Only
the data of cytokine secretion at 72 h post stimulation are
discussed in detail.
At 7 dpi, the PBMC of the re-infection group produced
significantly more TNF-α, IL-1β, IL-6 and IL-12p40 than
the PBMC of the other groups. At day 10, cytokine pro-
duction by PBMC was statistically the same for all groups.
At day 63, seven days post infection or re-infection of the
infection group and the re-infection group, respectively,
the mean concentrations of IFN-γ, TNF-α, IL-1β, IL-6,
IL-10 and IL-12p40 for the re-infection group were
significantly higher than the concentrations produced
by the PBMC of the other groups. At day 66, the PBMC
of the re-infected animals had produced significantly
more TNF-α, IL-1β, IL-6 and IL-10 than the PBMC of
the other animals. Furthermore, significantly more IL-8
and IL-12p40 was produced by the blood mononuclear
cells from the re-infection group when compared to the
infection group. For the infection group, mean IL-1β
and IL-10 concentrations in PBMC culture media were
significantly lower than for the control group.
At euthanasia, spleen MC of the infection group had
produced significantly less IFN-γ, TNF-α, IL-1β, IL-6,
IL-8 and IL-12p40 than MC of the other groups. The
production of TNF-α, IL-6 and IL-8 by cervical lymph
node MC was significantly higher for the control ani-
mals than for the infection or the re-infection group.
Mean IL-6 amounts produced by MC isolated from the
pelvic lymph nodes were significantly higher for the con-
trol group than for both infected groups. The MC from
pelvic lymph nodes of the infection group produced sig-
nificantly less IL-4 than the MC of the control group.
Histopathology
An overview of the mean scores of the histopathological
lesions found in the urogenital tract of the pigs at eu-
thanasia is presented in Table 6. Histopathological find-
ings consisted of: (a) intraluminal proteinaceous fluid;
(b) the presence of a superficial layer of exfoliated (epi-
thelial) cells and/or inflammatory cells: cells and debris
laying on the surface of the epithelium; (c) interepithelial
inflammatory cells, thus indicating the presence of migrat-
ing lymphocytes or polymorphonuclear cells in the epithe-
lium; (d) degeneration (vacuolation) and/or apoptosis (cell
death) of epithelial cells; (e) infiltration of inflammatory
cells in the lamina propria with infiltration of the connect-
ive tissue layer beneath the epithelium with polymorpho-
nuclear cells (pmc), a feature of more acute inflammation,
or with mononuclear cells (mnc) (lymphocytes and/or
plasma cells), a feature of more subacute to chronic in-
flammation; (f) oedema in the lamina propria: presence of
loosely arranged fibers in the connective tissue and/oreosinophilic fluid between the fibers; (g) infiltration of
inflammatory cells (pmc or mnc) in the muscular layer,
(h) or in the serosa. In the corpus uteri, both uterine horns
and the right oviduct mononuclear inflammatory cells
increased slightly in the mucosa with infection with C. suis
S45 (infection group) and even more when animals were
re-infected (re-infection group). The inflammatory cells in
the infection group were more periglandularly clustered in
the deep mucosa, whereas in the re-infection group the
inflammation was more diffusely present throughout the
mucosa. No lesions were noted in both ovaries and the
lesions observed in the left oviduct, the cervix, the vagina
and the urethra did not differ statistically between the dif-
ferent groups. In the liver of two pigs of the re-infection
group slight to moderate, focal to multifocal granuloma-
tous inflammations within the portal areas were noticed.
The same animals presented also minimal to slight diffuse
follicular hyperplasia in the spleen, a feature of immuno-
logical stimulation. The spleen and liver samples from the
remaining pigs and all caecum samples showed no histo-
pathological changes.
Discussion
Genital C. suis infections are likely to be transmitted
venereally, since these bacteria have been detected in the
semen of boars [1,12,13]. However, non-sexual transmis-
sion cannot be ruled out, for instance by fecal contamin-
ation of the vagina. In fact, C. suis has been commonly
detected in the gastrointestinal tract of pigs [33], and in
most of the cases it is associated with subclinical infec-
tions. Therefore, the gastrointestinal tract could serve as
a reservoir for chlamydial genital tract infection [34]. In
this study, female pigs were successfully infected in the
genital tract with C. suis strain S45, which was isolated
from feces of an asymptomatic pig. This indeed suggests
that persistent intestinal C. suis infections are able to
cause pathology in the genital tract of pigs.
In the present study, all infected animals showed gross
pathology at necropsy. However, the pigs that were in-
fected once had significantly more severe lesions than
the re-infected animals. Moreover, more chlamydial EBs
and inclusions were found in the urogenital tract of the
infection group than in the re-infected pigs. For the
infection group, chlamydial replication occurred through-
out the urogenital tract and even in the ovaries, whereas
for the re-infection group, inclusions were scarce. This
indicates that a certain level of protection against re-
infection was developed following primo-infection. This
presumption is in accordance with human epidemio-
logic studies suggesting that prior genital infection with
Chlamydia trachomatis, which is phylogenetically highly
related to C. suis, confers some short term protection
against re-infection [35,36]. Moreover, in all evaluated ani-
mal models of genital chlamydial infection, including the
Table 6 Mean scores ± standard deviations for histopathological findings#
Tissue Histopathological findings Control group Infection group Re-infection group
Vagina Exfoliation* 0.5 ± 1.00 0.2 ± 0.45 0.0 ± 0.00
Interepithelial inflammatory cells 0.0 ± 0.00 0.4 ± 0.55 0.2 ± 0.45
Degeneration and/or apoptosis of epithelial cells 0.0 ± 0.00 0.4 ± 0.55 0.4 ± 0.55
Infiltration of mnc in the lamina propria 1.5 ± 0.58 1.4 ± 0.55 1.2 ± 0.45
Cervix Interepithelial inflammatory cells 1.0 ± 0.82 0.8 ± 0.84 1.2 ± 0.84
Degeneration and/or apoptosis of epithelial cells 0.0 ± 0.00 0.2 ± 0.45 0.0 ± 0.00
Infiltration of mnc in the lamina propria 2.0 ± 0.82 1.4 ± 0.55 1.8 ± 0.84
Corpus Interepithelial inflammatory cells 1.0 ± 0.00 1.2 ± 0.45 1.2 ± 0.45
uteri Degeneration and/or apoptosis of epithelial cells 0.3 ± 0.50 0.2 ± 0.45 0.0 ± 0.00
Infiltration of mnc in the lamina propria 1.0 ± 0.00b 1.2 ± 1.30 2.0 ± 0.71b
Oedema lamina propria 2.3 ± 0.96 1.8 ± 1.30 1.4 ± 1.34
Uterine Exfoliation* 0.0 ± 0.00 0.0 ± 0.00 0.4 ± 0.89
Horn R Interepithelial inflammatory cells 1.3 ± 0.50 1.2 ± 0.45 1.2 ± 0.45
Degeneration and/or apoptosis of epithelial cells 0.3 ± 0.50 0.4 ± 0.55 0.0 ± 0.00
Infiltration of mnc in the lamina propria 1.3 ± 0.50b 2.2 ± 1.10 2.6 ± 0.55b
Oedema lamina propria 1.5 ± 0.58 1.6 ± 1.34 1.2 ± 1.30
Uterine Exfoliation* 0.0 ± 0.00 0.4 ± 0.89 0.0 ± 0.00
Horn L Interepithelial inflammatory cells 1.8 ± 0.50 1.8 ± 0.45 1.2 ± 0.45
Degeneration and/or apoptosis of epithelial cells 0.3 ± 0.50 0.8 ± 0.45 0.8 ± 0.45
Infiltration of mnc in the lamina propria 1.3 ± 0.50b 2.2 ± 1.10 2.4 ± 0.55b
Oedema lamina propria 1.0 ± 0.82 1.4 ± 0.55 1.0 ± 0.00
Oviduct R Intraluminal proteinaceous fluid 4 of 4 4 of 5 4 of 5
Exfoliation* 0.5 ± 0.58 0.0 ± 0.00 0.0 ± 0.00
Infiltration of mnc in the lamina propria 1.0 ± 0.00b 1.4 ± 0.55c 2.2 ± 0.45b,c
Oviduct L Intraluminal proteinaceous fluid 1 of 4 1 of 5 2 of 5
Exfoliation* 0.3 ± 0.50 0.2 ± 0.45 0.4 ± 0.55
Interepithelial inflammatory cells 0.0 ± 0.00 0.4 ± 0.55 0.6 ± 0.55
Infiltration of pmc in the lamina propria 0.3 ± 0.50 0.0 ± 0.00 0.0 ± 0.00
Infiltration of mnc in the lamina propria 1.3 ± 0.50 1.4 ± 0.89 1.4 ± 0.55
Urethra Interepithelial inflammatory cells 0.3 ± 0.50 0.2 ± 0.45 0.0 ± 0.00
Infiltration of mnc in the lamina propria 1.0 ± 0.00 0.8 ± 1.30 1.4 ± 1.52
#The mean scores ± SD for the histopathological parameters which are not shown in the table, were 0.0 ± 0.00 for the three groups.
*Superficial layer of exfoliated (epithelial) cells and/or inflammatory cells.
pmc: polymorphonuclear inflammatory cells; mnc: mononuclear inflammatory cells.
bP < 0.05 for a comparison of the control group and the re-infection group.
cP < 0.05 for a comparison of the infection group and the re-infection group.
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demonstrated that at least partial immunity to re-infection
develops. Nevertheless, vaginal inoculation with C. suis
resulted in an ascending infection in both groups. Like-
wise, C. trachomatis was able to ascend in the genital tract
of pigs after intravaginal inoculation [40]. No chlamydial
bacteria were detected outside the urogenital tract. With
the exception of the lymphogranuloma venereum strains,
C. trachomatis also does not disseminate beyond the
urogenital tract [41].Infection of the female porcine genital tract with C. suis
resulted microscopically in a slight increase of mono-
nuclear inflammatory cells in the mucosa of the corpus
uteri, both uterine horns and the right oviduct. Surpris-
ingly, this histopathological finding was even more
prominent when animals were re-infected, which is not
in accordance with the less severe macroscopic lesions
and the lower mean scores for the presence of chlamydial
bacteria observed in this group. However, these mono-
nuclear cells, including lymphocytes and plasma cells,
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to re-infection and can contribute to protective immunity
against infection. In the future, we will include immuno-
histochemistry to obtain in situ information on the cells
contributing to this partial protection. Schautteet et al.
[42] also observed that protection against gross lesions
was correlated with a higher infiltration of mononuclear
inflammatory cells in the genital tract mucosa of pigs
intravaginally infected with C. trachomatis.
Vaginal chlamydial excretion was observed in all infec-
ted animals from three dpi onwards. There were no differ-
ences noticed between shedding after primo-infection and
re-infection. Interestingly, vaginal excretion started to de-
crease gradually at four weeks post primo-infection and
one out of five animals stopped shedding chlamydial bac-
teria at 56 dpi. Since the animals were infected again at
that moment, we could not determine whether the pigs
were able to resolve a genital C. suis infection spontan-
eously after a certain period of time. Also, it would have
been interesting to follow up the animals for a longer
period than three weeks post re-infection in order to
assess whether chlamydial excretion stops earlier post
re-infection than post primo-infection.
Primo-infection with C. suis induced antichlamydial
IgM and IgG, but no IgA antibodies in sera and vaginal
secretions. Compared to the antibody responses after
primo-infection, re-infection with C. suis resulted in lower
IgM antibody titers and higher IgG and IgA titers in sera
and genital secretions, which is illustrative for a secondary
antibody response. Furthermore, re-infection was, in
contrast to primo-infection, able to induce C. suis-specific
proliferation of PBMC after 7 and 10 days, which in-
dicates the mobilization of memory cells in response
to re-infection. Re-infection was associated with a shift to
more B cells, monocytes and CD4−CD8+ T cells, but less
pDC and CD4+CD8− T cells within PBMC. However, the
immune responses detected in the blood do not necessar-
ily reflect the immune responses induced at the local site
of infection. Again, immunohistochemistry might assist in
determining the local responses. The shifts in immune cell
populations from the spleen, cervical and pelvic lymph
nodes are presumably not resulting from C. suis-specific
MC since their proliferative responses were not statisti-
cally different between groups.
Primary genital C. suis infection of the re-infection
group (nine-week-old pigs) resulted in increased secretion
of TNF-α, IL-1β, IL-6 and IL-12p40 by PBMC, whereas
primo-infection of the infection group (seventeen-week-
old animals) decreased the IL-1β, IL-8 and IL-10 secretion
by PBMC. This discrepancy could be due to age differ-
ences between both groups at the moment of the primo-
infection. In pigs, various aspects of the immune system
change with age such as the level of NK cells, which was
shown to be higher in younger pigs [43,44]. Since NK cellsproduce cytokines like TNF-α, this can explain the higher
cytokine production following primo-infection at nine
weeks of age. Furthermore, it was demonstrated that neo-
natal porcine blood DCs were more responsive to stimula-
tion with toll-like receptor ligands than adult porcine
blood DCs, since they showed higher expression levels
of cytokines and chemokines following stimulation [45].
After re-infection, higher concentrations of IFN-γ and
IL-10 were produced by PBMC, next to higher amounts
of the cytokines upregulated after primo-infection.
Our data suggest that antibody producing B cells,
mononuclear phagocytes, CD8+ T cells, and IFN-γ may
contribute to protection against a genital C. suis infection.
The role of IL-10 is less clear. Antibodies, and especially
mucosal antibodies, albeit not considered as crucial, may
contribute to protection by neutralization and opsoni-
zation of extracellular Chlamydia. Indeed, antibodies
clearly play an important role in resistance to genital
Chlamydia muridarum re-infection in mice [46]. More-
over, mucosal antichlamydial IgA antibodies have been
associated with the resolution of C. muridarum and C.
trachomatis infection in mice and women, respectively
[47,48]. The Th1-type cytokine IFN-γ was also shown to
be essential for the resolution of C. muridarum infection
[49,50]. IFN-γ produced by NK cells, CD4+ Th1 cells and
CD8+ cytotoxic T cells is known to up-regulate and/or
induce expression of major histocompatibility complex
(MHC) class I and II molecules on a number of cells,
including antigen presenting cells. In addition, IFN-γ
favours immunoglobulin class switching to the IgG2a
isotype and activation of cytotoxic T lymphocytes,
which induce apoptosis in infected cells. IL-10, as the
main anti-inflammatory cytokine, plays important roles
in immune-homeostasis after microbe elimination [51].
IL-10 expression results in an inhibition of antigen pres-
entation and MHCII expression on the surface of infected
cells. However, as an anti-inflammatory cytokine, it also
deactivates macrophages and interferes with the Th1
response through inhibition of the NF-κB pathway [52].
Interestingly, Moore-Connors et al. [53] showed that C.
muridarum induces a novel CD43−CD1dhiCD5+ IL-10-
producing regulatory B cell population (Bregs) during a
genital infection in mice. These IL-10 producing B cells
displayed bona fide regulatory Breg activity by potently
suppressing IFN-γ production in vitro in an IL-10-
dependent manner. We do not know if these IL-10 produ-
cing CD43−CD1dhiCD5+ Bregs do exist in the pig and if
they can be induced by C. suis, but it could be a possible
explanation for our observation that CD4+ Th1 cells,
which are generally considered as crucial immune effec-
tors in antichlamydial immunity, were less dominantly
present.
In conclusion, we demonstrated that C. suis strain S45
is pathogenic for the female porcine urogenital tract.
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genital tract, causing inflammation and pathology. Fur-
thermore, genital infection elicited both cellular and
humoral immune responses. Compared to the primo-
infection of pigs with C. suis, re-infection was character-
ized by less severe macroscopic lesions and significantly
less chlamydial EBs and inclusions in the urogenital
tract. This indicates the development of a certain degree
of protection following the initial infection. Protective
immunity against re-infection coincided with higher
antichlamydial IgG and IgA antibody titers in sera and
vaginal secretions, higher proliferative responses of per-
ipheral blood mononuclear cells (PBMC), higher percent-
ages of blood B lymphocytes, monocytes and CD8+ T
cells and upregulated production of IFN-γ and IL-10
by PBMC.Additional files
Additional file 1: Macroscopic lesions in an animal from the
infection group. Additional file 1 shows the most prominent gross
pathology in the infection group at euthanasia. (A) Congestion of the
lig. latum uteri (arrow a) and the mesovarium and mesosalpinx (arrow b).
A large amount of clear watery exudate was present in the lumen of the
vagina, cervix, corpus uteri (arrow c) and uterine tubes. The uterine tubes
were severely dilated by the presence of the exudate in their lumen
(arrow d). (B) Congestion of the mesovarium and mesosalpinx (arrow e).
Hyperemia of the uterine tube (arrow f). The mucosa of the uterine tube
is congested and oedematous and serous exudate was present in the
lumen (arrow g).
Additional file 2: Mean percentage ± standard deviation of different
immune cell populations within PBMC, isolated at 7 and 10 days
post infection or re-infection, and in spleen, cervical and pelvic
lymph nodes at euthanasia. Additional file 2 presents the mean
percentages of total T cells, γδ T cells, mature and IgM+ B cells,
monocytes, NK cells and plasmacytoid dendritic cells in the blood at
different time points post infection and in the spleen, cervical and pelvic
lymph nodes at euthanasia.
Additional file 3: Mean percentage of different subpopulations
within total T cells (CD3+) in the blood, isolated at 7 and 10 days
post infection or re-infection, and in spleen, cervical and pelvic
lymph nodes at euthanasia. Additional file 3 shows the mean
percentages of CD4+CD8−, CD4−CD8+, CD4+CD8+ and CD4−CD8−
subpopulations within total T cells in the blood at different time points
post infection and in the spleen, cervical and pelvic lymph nodes at
euthanasia.
Additional file 4: Mean cytokine concentration (pg/mL) ± standard
deviation in culture medium of PBMC, isolated at 7 and 10 days
post infection or re-infection, and of spleen, pelvic and cervical
lymph node MC at euthanasia, measured at 16 h post stimulation
with C. suis S45. Additional file 4 presents the results for cytokine
detection at 16 h post stimulation.
Additional file 5: Mean cytokine concentration (pg/mL) ± standard
deviation in culture medium of PBMC, isolated at 7 and 10 days
post infection or re-infection, and of spleen, pelvic and cervical
lymph node MC at euthanasia, measured at 72 h post stimulation
with C. suis S45. Additional file 5 presents the results for cytokine
detection at 72 h post stimulation.Competing interests
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